Dr./M.D. Parichehr Shamsrizi

Background

Dr. Parichehr Shamsrizi studied human medicine at the University of Tübingen and earned her doctorate in infectious disease research on the topic of antibiotic resistance. Since 2019, she has been working at the Bernhard Nocht Institute for Tropical Medicine in Hamburg. Until 2022, she was involved in tropical medicine, clinical infectious disease research, and vaccine development in collaboration with the University Medical Center Hamburg-Eppendorf. After a stay at the European Centre for Disease Prevention and Control (ECDC) in Stockholm, she became a postdoctoral researcher in the Health Communication research group at the Bernhard-Nocht-Institute for Tropical Medicine and the Institute for Planetary Health Behaviour at the University of Erfurt Currently, she is conducting research within the PACE study on knowledge, behavior, trust, perception, communication, and willingness to act in the context of planetary health. The PACE study also gave rise to the "CliMed" project, which Dr. Shamsrizi leads. In this project, she explores the role of medical professionals in climate communication. Additionally, she contributes to the HEATCOM project.

Dr. Shamsrizi is also a member of ThinkTank30 of the Club of Rome Germany.

Areas of expertise: climate and health, infectious diseases, vaccination behaviour

Curriculum Vitae

Academic career

• 2021 – 2023          Epidemiology, London School of Hygiene and Tropical Medicine, University of London (UK)
• 2015 – 2021          MD Thesis (Dr.med.), Eberhard Karls University, Tübingen
• 2011 – 2018          Medical School (approbation: 2018), Eberhard Karls University, Tübingen

Employment

• 2022 – present      Post-doctoral researcher in the working group of Cornelia Betsch, Health Communication, Department of Implementation Research, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg (Project Lead CliMed: Climate and Health Communication by Medical Professionals, funded by: Stiftung Mercator GmbH)
• 2020 – 2022          Clinician scientist in the working group of Marylyn Addo, Institute for Infectious Research and Vaccine Development & Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf
• 2019 – 2020           Research Associate and Investigator, Travel Clinic, Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & Department of Medicine, University Medical Center Hamburg-Eppendorf
• 2019 – 2020           Physician, Travel Clinic, Division of Tropical Medicine, Department of Medicine, University Medical Center Hamburg-Eppendorf
• 2015 – 2021           PhD Student, Tacconelli Research Group, Department of Infectious Diseases, University Hospital Tübingen

Memberships

• since 2022            ThinkTank30 of the Club of Rome Germany
• since 2019            German Society for Tropical Medicine and Global Health (DTG)
• since 2016            European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

Volunteer Work

• Since 2019             Amnesty International Deutschland e.V.
• Since 2019             Women’s Health Team, Hamburg

Full CV for Dr. med. Parichehr Shamsrizi (PDF)

Publications

• Felgendreff, L., Rebitschek, F. G., Geiger, M., Shamsrizi, P., Jenny, M. A., & Betsch, C. (2024). Explaining the Mechanism Behind mRNA Vaccines Influences Perceived Vaccine Effectiveness but not Vaccination Intentions: A Randomized Experiment. European Journal of Health Communication, 5(1), 21–45. https://doi.org/10.47368/ejhc.2024.102
• Eitze, S., Sprengholz, P., Korn, L., Shamsrizi, P., Felgendreff, L. & Betsch, C. (2024). Vicarious experiences of long COVID: A protection motivation theory analysis for vaccination intentions. Vaccine: X, 16, 100417. https://doi.org/10.1016/j.jvacx.2023.100417
• Mahajan, U.M., Erber, J., Shamsrizi, P... & Stubbe, H.C. (2023). Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study. Infection, 51, 1669–1678. https://doi.org/10.1007/s15010-023-02041-8
• Lehrer, L., Geiger, M., Sprengholz, Ph., Jenny, M. A., Temme, H., Shamsrizi, P., Eitze, S. & Betsch, C. (2023, September 17). Study Protocol of the Planetary Health Action Survey PACE – A serial cross-sectional survey to assess the general population’s readiness to act against the climate crisis in Germany. PsyArXiv. doi.org/10.31234/osf.io/jcwv7
• Shamsrizi, P., Jenny, M. A., Sprengholz P., Geiger, M., Jäger, C. B., & Betsch, C. (2023). Heatwaves and their health risks: knowledge, risk perceptions and behaviours of the German population in summer 2022, European Journal of Public Health, 33(5), 841–843. https://doi.org/10.1093/eurpub/ckad109
• Jenny, M. A., Lehrer, L., Eitze, S., Sprengholz, P., Korn, L., Shamsrizi, P., Geiger, M., Hellmann, L., Mai, L., Maur, K., & Betsch, C. (2022). Accelerating climate protection by behavioural insights: The Planetary Health Action Survey (PACE). The Lancet Planetary Health, 6, 19. https://doi.org/10.1016/S2542-5196(22)00281-9
• Memenga, P., Eitze, S., Shamsrizi, P., Addo, M. M., & Betsch, C. (2022). Debunking Misinformation and Communicating Critical Events in Vaccine Trials: Experimental Evidence on Vaccination Intentions in SARS-CoV-2 Pandemic. European Journal of Health Communication, 3(2), 64–96. https://doi.org/10.47368/ejhc.2022.204
• Shamsrizi, P., Kramer, F. J., Addo, M. M., Fathi, A. (2021) Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial. Vaccines, 9(10), 1208. https://doi.org/10.3390/vaccines9101208
• Koch, T., Mellinghoff, S. C., Shamsrizi, P., Addo, M. M. & Dahlke C. (2021). Correlates of Vaccine-Induced Protection against SARS-CoV-2. Vaccines, 9(3), 238. https://doi.org/10.3390/vaccines9030238
• Gabor, J. J., Kreidenweiss, A., Weber, S., Salama, M., Sulyok, M., Sulyok, Z., Koehne, E., Esen, M., Kreuels, B., Shamsrizi, P., Biecker, E., Mordmüller, B., Berg, C. P., Fusco, S., Köhler, C., Kubicka, S., Leitlein, J., Addo, M., Ramharter, M., Schwab, M., ... & Kremsner, P. G. (2021). A call to caution when hydroxychloroquine is given to elderly COVID-19 patients. International Journal of Infectious Diseases, 106, 265-268.
  https://doi.org/10.1016/j.ijid.2021.04.009
• Velevan, T.P., Kuk, S., Linh, L. T. K., Lamsfus Calle, C., Lalremuruata, A., Pallerla, S., R., Kreisenweiss, A., Held, J., Esen, M., Gabor, J., Neurohr, E. M., Shamsrizi, P., Fathi, A., Biecker, E., Berg, C. P., Ramharter, M., Addo, M. M., Kreuels, B., Kremsner, P. G.(2021). Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. Scientific Reports, 11, 14471. https://doi.org/10.1038/s41598-021-93950-x
• Betsch, C., Korn, L., Felgendreff, L., Eitze, S., Schmid, P., Sprengholz, P., Wieler, L., Schmich, P., Stollorz, V., Ramharter, M., Bosnjak, M., Omer, S. B., Thaiss, H., De Bock, F., Von Rüden, U., & Shamsrizi, P., (2020). COVID-19 Snapshot Monitoring (COSMO Germany) - Wave 24 [Data set]. PsychArchives. https://doi.org/10.23668/PSYCHARCHIVES.4317
• Shamsrizi, P., Jochum, J., Kreuels, B. & Ramharter, M., (2020). Traveling into the Abyss: Risk Perception of German Travelers at the Onset of the COVID-19 Pandemic. The American Journal of Tropical Medicine and Hygiene, 103(4), 1640-1641. https://doi.org/10.4269/ajtmh.20-0892
• Shamsrizi, P., Gladstone, B. P., Carrara, E., Luise, D., Cona, A., Bovo, C. & Tacconelli, E. (2020). Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. BMJ Open, 10, e030266. https://doi.org/10.1136/bmjopen-2019-030266.
• Shamsrizi, P., & Bühler, S. (2019). Travel Medicine 4th Edition, book review. Travel Medicine and Infectious Disease, 32, 101529. https://doi.org/10.1016/j.tmaid.2019.101529
• Gladstone, B. P., Cona, A., Shamsrizi, P., Vilken, T., Kern, W. V., Malek, N. & Tacconelli, E., (2017). Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use. PLoS One, 12(7): e0181358. https://doi.org/10.1371/journal.pone.0181358